Daily Archives: September 5, 2022
Consensus Statement | Preoperative management of cardiovascular medications.
5 Sep, 2022 | 14:42h | UTCRelated:
Preoperative Management of Medications for Neurologic Diseases – Mayo Clinic Proceedings
Preoperative Management of Surgical Patients Using Dietary Supplements – Mayo Clinic Proceedings
Perioperative Evaluation and Management of Endocrine Disorders – Mayo Clinic Proceedings
Preoperative Cardiac Risk Assessment – Mayo Clinic Proceedings
Preoperative Evaluation Before Noncardiac Surgery – Mayo Clinic Proceedings
Perioperative Cardiac Risk Reduction in Noncardiac Surgery – Mayo Clinic Proceedings
Perioperative Venous Thromboembolism Prophylaxis – Mayo Clinic Proceedings
RCT | Efficacy of prednisolone for Bell Palsy in children.
5 Sep, 2022 | 14:39h | UTCEfficacy of Prednisolone for Bell Palsy in Children: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial – Neurology (link to abstract – $ for full-text)
Commentary on Twitter
In children with Bell's palsy the vast majority recover without treatment. The study, although underpowered, does not provide evidence that early treatment with prednisolone improves complete recovery.https://t.co/QUVA14vZDG
— Santi Mintegi (@MintegiSanti) August 29, 2022
RCT | Bronchodilators don’t improve smoking-related respiratory symptoms in people without COPD.
5 Sep, 2022 | 14:40h | UTCNews Release: Bronchodilators don’t improve smoking-related respiratory symptoms in people without COPD – NIH News Releases
Original Study: Bronchodilators in Tobacco-Exposed Persons with Symptoms and Preserved Lung Function – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary on Twitter
This trial involving symptomatic, tobacco-exposed persons with preserved lung function onspirometry showed no benefit to the use of dual bronchodilator therapy. https://t.co/kXqXHMl2xx pic.twitter.com/KAMuI4Jajo
— NEJM (@NEJM) September 4, 2022
Perspective | Science, competing values, and trade-offs in public health — the example of Covid-19 and masking.
5 Sep, 2022 | 14:37h | UTC
FDA authorizes updated COVID boosters from Moderna and Pfizer.
5 Sep, 2022 | 14:36h | UTCFDA authorizes updated COVID boosters from Moderna and Pfizer – CIDRAP
FDA News Release: Coronavirus (COVID-19) Update: FDA Authorizes Moderna, Pfizer-BioNTech Bivalent COVID-19 Vaccines for Use as a Booster Dose – U.S. Food & Drug Administration
Opinion | People with terminal cancer need to know they are dying. Doctors shouldn’t withhold that information.
5 Sep, 2022 | 14:35h | UTC
Cohort Study | Habitual alcohol intake and risk of atrial fibrillation in young adults.
5 Sep, 2022 | 14:33h | UTCHabitual Alcohol Intake and Risk of Atrial Fibrillation in Young Adults in Korea – JAMA Network Open
Invited Commentary: Self-reported Alcohol Consumption and Risk of Atrial Fibrillation – JAMA Network Open
European guideline (EuroGuiDerm) on atopic eczema – Part II | Non-systemic treatments and treatment recommendations for special AE patient populations.
5 Sep, 2022 | 14:32h | UTC
A pilot study showed GnRH replacement could improve cognition in Down syndrome.
5 Sep, 2022 | 14:34h | UTCGnRH replacement rescues cognition in Down syndrome – Science (link to abstract – $ for full-text)
News Release: A therapy found to improve cognitive function in patients with Down syndrome – INSERM
Commentary: A Hormone May Boost Cognition in Down Syndrome – Scientific American
Joint Position Paper | Organ donation after circulatory determination of death in India.
5 Sep, 2022 | 14:31h | UTC
Review | Right ventricular function across the spectrum of health and disease.
5 Sep, 2022 | 14:30h | UTCRight ventricular function across the spectrum of health and disease – Heart
Commentary on Twitter
Right ventricular function across the spectrum
of health and disease https://t.co/3i9iiddsyV #echofirst #Cardiotwitter #CardioEd #MedEd #CardioTwitteros pic.twitter.com/Q219nvnu6v— Sergio Moreno M (@Serginho1409) July 11, 2022
Under a http://creativecommons.org/licenses/by-nc/4.0/ license
Brief Review | What’s new in pediatric ventilator liberation?
5 Sep, 2022 | 14:29h | UTCWhat’s new in paediatric ventilator liberation? – Intensive Care Medicine
Commentary on Twitter
Pediatric ventilator liberation, update
⚙️ assess/adjustment of MV & sedation
⚙️ prepare
⚙️ extubate
⚙️ support
Many questions unanswered! peri-extubation steroids, criteria for NIV after extubation, post-extubation rescue HFNC vs CPAP.#PedsICU #FOAMcc
?️ https://t.co/MGPStTvZh2 pic.twitter.com/AySzk9blS5— Intensive Care Medicine (@yourICM) September 2, 2022
The Australian obesity management algorithm: a simple tool to guide the management of obesity in primary care.
5 Sep, 2022 | 14:31h | UTC
5-year follow-up of a RCT | Five-year outcomes of FOLFIRINOX vs. Gemcitabine as adjuvant therapy for pancreatic cancer.
5 Sep, 2022 | 14:26h | UTCFive-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer: A Randomized Clinical Trial – JAMA Oncology (link to abstract – $ for full-text)
Commentary on Twitter
Updated 5-year results of the Unicancer PRODIGE 24/CCTG PA6 trial confirmed the significant improvement in all outcomes, including overall survival, with mFOLFIRINOX regimen compared to gemcitabine in adjuvant setting for pts w #pancreaticcancer. https://t.co/rCFntho0f1 #GICSM pic.twitter.com/VAVBD7o6kc
— JAMA Oncology (@JAMAOnc) September 1, 2022
RCT | Maintaining continuous endotracheal cuff pressure control through an automated electronic device did not reduce the incidence of ventilator-associated respiratory infection.
5 Sep, 2022 | 14:25h | UTC
Brief Review | Monitoring of renal perfusion.
5 Sep, 2022 | 14:27h | UTCMonitoring of renal perfusion – Intensive Care Medicine
Commentary on Twitter
Hypoperfusion long considered among main predisposing factors for #AKI in #ICU; this recently challenged ie #sepsis. How to monitor renal perfusion?
? RI doppler-based renal resistive index/RI change
? CEUS
? RVI renal venous impedance index#FOAMcc
?️ https://t.co/Eejruztegw pic.twitter.com/KLCksRjx6U— Intensive Care Medicine (@yourICM) September 3, 2022
Review | The prevention and treatment of nausea and vomiting during tumor therapy.
5 Sep, 2022 | 14:23h | UTCThe Prevention and Treatment of Nausea and Vomiting During Tumor Therapy – Deutsches Ärzteblatt International
Related:
SEOM clinical guideline emesis (2021) – Clinical and Translational Oncology
Prevention of Chemotherapy-Induced Nausea and Vomiting in the Older Patient: Optimizing Outcomes – Drugs & Aging (if the link is paywalled, try this one)
RCT | Reduction of nonoperative time using the induction room, parallel processing, and Sugammadex.
5 Sep, 2022 | 14:24h | UTC
RCT | Comparison of rhomboid intercostal block, erector spinae plane block, and serratus plane block on analgesia for video-assisted thoracic surgery.
5 Sep, 2022 | 14:22h | UTC
Review | Small intestinal bacterial overgrowth breath testing in gastroenterology: clinical utility and pitfalls.
5 Sep, 2022 | 14:21h | UTC
30-month follow-up analysis of a RCT | Pembrolizumab vs. placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma.
5 Sep, 2022 | 14:20h | UTCInvited Commentary: Adjuvant immunotherapy for renal cell carcinoma – The Lancet Oncology
Original Article: Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma – New England Journal of Medicine
RCT | Telaglenastat failed to improve the efficacy of Cabozantinib in patients with advanced renal cell carcinoma.
5 Sep, 2022 | 14:19h | UTCEfficacy and Safety of Telaglenastat Plus Cabozantinib vs Placebo Plus Cabozantinib in Patients With Advanced Renal Cell Carcinoma: The CANTATA Randomized Clinical Trial – JAMA Oncology (free for a limited period)
Commentary on Twitter
The CANTATA randomized trial of the glutaminase inhibitor telagenastat or placebo added to cabozantinib in patients with metastatic clear cell renal cell carcinoma (RCC) demonstrated no improvement in efficacy with addition of telagenastat https://t.co/r9j2wmjnlF #GUCSM pic.twitter.com/ovXXEAXqi0
— JAMA Oncology (@JAMAOnc) September 1, 2022
Nonalcoholic fatty liver disease: review of management for primary care providers.
5 Sep, 2022 | 14:18h | UTC
Volatile anesthetics for ICU sedation: the future of critical care or niche therapy?
5 Sep, 2022 | 14:16h | UTC
Commentary on Twitter
Volatile anesthetics for #ICU sedation
➡️ ventilators adaptable to deliver
➡️ effective even in #ARDS
➡️ rapid on/offset, no accumulation
➡️ analgesic effect: opioid-sparing?
➡️ may preserve spont breathing
➡️ immunomodulatory/organ-protective effects?
?️ https://t.co/XZAJgElwYs pic.twitter.com/dTpsaued8V— Intensive Care Medicine (@yourICM) September 4, 2022
Systematic Review | Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
5 Sep, 2022 | 14:15h | UTC